DSCM
ANGO icon

Divisadero Street Capital Management’s AngioDynamics ANGO Stock Holding History

Divisadero Street Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-562,153
Closed -$6.39M – 146
2026
Q1 		$6.39M Buy
+562,153
New +$6.09M 0.27% 57
2025
Q4 		– Sell
-3,678,125
Closed -$41.1M – 98
2025
Q3 		$41.1M Buy
3,678,125
+282,695
+8% +$2.73M 1.79% 15
2025
Q2 		$33.7M Buy
3,395,430
+2,435,365
+254% +$23.8M 2.15% 12
2025
Q1 		$9.02M Buy
960,065
+445,430
+87% +$4.68M 0.91% 32
2024
Q4 		$4.71M Buy
+514,635
New +$3.78M 0.55% 40

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Divisadero Street Capital Management's ANGO Position: Q2 2026 in Review

Divisadero Street Capital Management sold out of AngioDynamics (ANGO) in Q2 2026, closing a stake of 562,153 shares — an estimated $6.39M sold.

Divisadero Street Capital Management first reported a position in ANGO in Q4 2024 and held it in 5 quarters. The position peaked at $41.1M in Q3 2025. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Divisadero Street Capital Management reported no remaining AngioDynamics position as of Q2 2026 after selling out during the quarter.
  • Divisadero Street Capital Management sold 562,153 AngioDynamics shares in Q2 2026, an estimated $6.39M.
  • Divisadero Street Capital Management first reported a position in AngioDynamics in Q4 2024 and held it in 5 quarters.
  • Divisadero Street Capital Management's AngioDynamics position peaked at $41.1M in Q3 2025.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Divisadero Street Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.